Winship Cancer Institute and Emory University researchers are contributing to major presentations and are actively involved at the Annual Meeting of the American Society of Hematology, December 8 to 11 in Atlanta.

“Innovative research and enrollment of patients in promising clinical trials has put Winship at the forefront of the progress that’s been made against blood cancers,” says Walter J. Curran, MD, executive director of Winship Cancer Institute of Emory University, “and these efforts are recognized by the strong presence and participation of our doctors and researchers at ASH.” 

“Winship and Emory faculty will present more than 100 scientific papers in the form of posters and oral presentations, and this is a testimony of our strong commitment at Emory to not only contribute but drive advancements in the field of cancer and blood disorders,” says Fadlo R. Khuri, MD, chairman of the Department of Hematology and Medical Oncology.

Emory physicians and scientists will participate as influential members of various committees that define the priorities and mission of the Society (Education Committee, Practice Committee and Governmental Affairs Committee), and will share their research during this four-day meeting attended by more than 20,000 hematologists from around the world. 

Scientific papers that will be presented summarize extensive research conducted at Emory in the field of multiple myeloma, lymphoma, leukemia, myeloproliferative disorders and stem cell transplantation. Selected high-impact abstracts (Winship and Emory faculty highlighted in bold) are listed on the Winship Cancer Institute website.